SIGLEC15 and cancer: We found that VSIR exhibited a close positive correlation with these immune checkpoints in most cancers, especially with LAIR1, HAVCR2, SIGLEC15, IDO1, CD274, HAVCR2, PDCD1, CTLA-4, LAG3, and PDCD1LG2.